These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 39227791)

  • 1. Treatment of ocular surface squamous neoplasia in an Indian rural facility: a study of 38 eyes.
    Agarwal A; Ghose N; Rathi V; Khanna R; Kaliki S
    BMC Ophthalmol; 2024 Sep; 24(1):389. PubMed ID: 39227791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
    Venkateswaran N; Mercado C; Galor A; Karp CL
    Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes.
    Bakal K; Molugu S; Machakuri K; Bejjanki KM; Kapoor AG; Kaliki S
    Int Ophthalmol; 2024 Jun; 44(1):251. PubMed ID: 38907750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment.
    Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
    Chaugule SS; Park J; Finger PT
    Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of topical 0.5% 5-Fluorouracil as primary treatment of ocular surface squamous neoplasia.
    Kato JM; Ballalai PL; de Lima PP; Santo RM
    Can J Ophthalmol; 2024 Oct; 59(5):e510-e514. PubMed ID: 38631493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up study.
    Wylegala A; Sripawadkul W; Zein M; Alvarez OP; Al Bayyat G; Galor A; Karp CL
    Ocul Surf; 2023 Jan; 27():67-74. PubMed ID: 36476665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular surface squamous neoplasia in India: a study of 438 patients.
    Kaliki S; Vempuluru VS; Ghose N; Gunda S; Vithalani NM; Sultana S; Ganguly A; Bejjanki KM; Jakati S; Mishra DK
    Int Ophthalmol; 2022 Jun; 42(6):1915-1926. PubMed ID: 35094225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.
    Joag MG; Sise A; Murillo JC; Sayed-Ahmed IO; Wong JR; Mercado C; Galor A; Karp CL
    Ophthalmology; 2016 Jul; 123(7):1442-8. PubMed ID: 27030104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon Alfa-2b for Pigmented Ocular Surface Squamous Neoplasia: A Report of 8 Lesions.
    Kaliki S; Sharma A; Vempuluru VS
    Cornea; 2021 Feb; 40(2):142-146. PubMed ID: 32355112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Sinha B; Kumar R
    Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.
    Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL
    Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal squamous neoplasia: masquerades and management outcomes at a rural eyecare centre.
    Agarwal A; Kaliki S; Murthy SI
    BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37130635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
    Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
    Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term study of topical interferon α-2b eye drops as primary treatment of ocular surface squamous neoplasia.
    Sripawadkul W; Reyes-Capo D; Zein M; Wylegala A; Albayyat G; Galor A; Karp CL
    Ocul Surf; 2023 Apr; 28():108-114. PubMed ID: 36592780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.
    Parrozzani R; Frizziero L; Trainiti S; Testi I; Miglionico G; Pilotto E; Blandamura S; Fassina A; Midena E
    Br J Ophthalmol; 2017 Aug; 101(8):1094-1099. PubMed ID: 27941046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral ocular surface squamous neoplasia: A study of 25 patients and review of literature.
    Vempuluru VS; Pattnaik M; Ghose N; Kaliki S
    Eur J Ophthalmol; 2022 Jan; 32(1):620-627. PubMed ID: 33818167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
    Kaliki S; Bejjanki KM; Desai A; Mohamed A
    Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular surface squamous neoplasia in xeroderma pigmentosum: clinical spectrum and outcome.
    Gupta N; Sachdev R; Tandon R
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1217-21. PubMed ID: 21484462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.